Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Effectiveness of glecaprevir/p...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

Bibliographic Details
Main Authors: Aleksandra Berkan-Kawińska, Anna Piekarska, Hanna Berak, Włodzimierz Mazur, Aleksander Garlicki, Magdalena Tudrujek-Zdunek, Beata Lorenc, Dorota Dybowska, Łukasz Socha, Anna Parfieniuk-Kowerda, Robert Flisiak
Format: Article
Language:English
Published: Termedia Publishing House 2024-07-01
Series:Clinical & Experimental Hepatology
Subjects:
hiv/hcv coinfection
daa treatment
glecaprevir/pibrentasvir
bictegravir/emtricitabine/tenofovir alafenamide
Online Access:https://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.html

Similar Items

  • RP-HPLC method development and validation for the estimation of Emtricitabine, Bictegravir and Tenofovir alafenamide in bulk and pharmaceutical dosage form
    by: Tej Kumar Kokkirala, et al.
    Published: (2019-12-01)
  • Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
    by: Hernando Knobel, et al.
    Published: (2023-12-01)
  • Clinical efficacy, safety, and subjective experience based on ePRO in HIV‐infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China
    by: Linghong Kong, et al.
    Published: (2023-08-01)
  • Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
    by: Desmond Y. H. Yap, et al.
    Published: (2020-10-01)
  • Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study
    by: Lin Gan, et al.
    Published: (2024-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs